{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:55:26Z","timestamp":1782215726613,"version":"3.54.5"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004505","name":"Universit\u00e0 degli Studi di Catania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetic gastroparesis (DGP) is a chronic and frequently underrecognized complication of diabetes mellitus, characterized by delayed gastric emptying in the absence of mechanical obstruction. It represents a clinically significant manifestation of diabetic autonomic neuropathy and arises from a complex interplay of sustained hyperglycemia, oxidative and nitrosative stress, advanced glycation end-product accumulation, impaired insulin\/IGF-1 signaling, lipid dysmetabolism, and inflammatory activation. These mechanisms converge to damage autonomic and enteric neurons, reduce interstitial cells of Cajal density, and disrupt gastric smooth muscle function, ultimately leading to impaired and unpredictable gastric motility. Beyond gastrointestinal symptoms, DGP profoundly affects metabolic control. The altered timing and variability of gastric emptying disturb the physiological coordination between nutrient absorption and insulin pharmacokinetics, generating a temporal mismatch that predisposes patients to early postprandial hypoglycemia followed by late hyperglycemia. This pattern increases glycemic variability, complicates insulin dose adjustment, and contributes to oxidative stress and vascular risk. In this narrative review, we examine the current understanding of DGP pathophysiology and its clinical implications for insulin therapy. We discuss diagnostic strategies, nutritional interventions, and pharmacological treatments, with particular attention to insulin timing modulation. We also analyze the emerging role of diabetes technologies, including continuous glucose monitoring and automated insulin delivery systems, as well as future perspectives such as glucose-responsive insulins and regenerative approaches targeting gastric neuromuscular dysfunction. A mechanism-based, personalized therapeutic strategy may improve metabolic stability and patient outcomes.<\/jats:p>","DOI":"10.1007\/s12020-026-04693-6","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:27:09Z","timestamp":1782214029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetic gastroparesis: pathophysiology and impact on insulin timing choices"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4104-1105","authenticated-orcid":false,"given":"Francesco","family":"Galeano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5820-4178","authenticated-orcid":false,"given":"Andrea","family":"Tumminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5210-8601","authenticated-orcid":false,"given":"Vittorio","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1398-9271","authenticated-orcid":false,"given":"Rosario","family":"Le Moli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0567-6494","authenticated-orcid":false,"given":"Tommaso","family":"Piticchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Scilletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-6101","authenticated-orcid":false,"given":"Maurizio","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1705-2782","authenticated-orcid":false,"given":"Antonino","family":"Di Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-3201","authenticated-orcid":false,"given":"Francesco","family":"Frasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"4693_CR1","doi-asserted-by":"publisher","unstructured":"A. Verrotti, G. Prezioso, R. Scattoni, F. Chiarelli, Autonomic neuropathy in diabetes mellitus. Front. Endocrinol. (Lausanne). 5 (2014). https:\/\/doi.org\/10.3389\/FENDO.2014.00205","DOI":"10.3389\/FENDO.2014.00205"},{"key":"4693_CR2","doi-asserted-by":"publisher","first-page":"S252","DOI":"10.2337\/DC25-S012","volume":"48","author":"ADAPP Committee","year":"2025","unstructured":"A.D.A.P.P. Committee, N.A. ElSayed, R.G. McCoy et al., 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes\u20142025. Diabetes Care. 48, S252\u2013S265 (2025). https:\/\/doi.org\/10.2337\/DC25-S012","journal-title":"Diabetes Care"},{"key":"4693_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.14309\/AJG.0000000000001874","volume":"117","author":"M Camilleri","year":"2022","unstructured":"M. Camilleri, B. Kuo, L. Nguyen et al., ACG Clinical Guideline: Gastroparesis. Am. J. Gastroenterol. 117, 1197 (2022). https:\/\/doi.org\/10.14309\/AJG.0000000000001874","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMCP062614","volume":"356","author":"M Camilleri","year":"2007","unstructured":"M. Camilleri, Diabetic Gastroparesis. N Engl. J. Med. 356, 820\u2013829 (2007). https:\/\/doi.org\/10.1056\/NEJMCP062614","journal-title":"N Engl. J. Med."},{"key":"4693_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/BF00403371","volume":"37","author":"M Horowitz","year":"1994","unstructured":"M. Horowitz, R. Fraser, Disordered gastric motor function in diabetes mellitus. Diabetologia. 37, 543\u2013551 (1994). https:\/\/doi.org\/10.1007\/BF00403371","journal-title":"Diabetologia"},{"key":"4693_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/J.1572-0241.2007.01658.X","volume":"103","author":"YR Wang","year":"2008","unstructured":"Y.R. Wang, R.S. Fisher, H.P. Parkman, Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995\u20132004. Am. J. Gastroenterol. 103, 313\u2013322 (2008). https:\/\/doi.org\/10.1111\/J.1572-0241.2007.01658.X","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR7","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/J.GASTRO.2004.09.055","volume":"127","author":"HP Parkman","year":"2004","unstructured":"H.P. Parkman, W.L. Hasler, R.S. Fisher, American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 127, 1592\u20131622 (2004). https:\/\/doi.org\/10.1053\/J.GASTRO.2004.09.055","journal-title":"Gastroenterology"},{"key":"4693_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cgh.2010.09.022","volume":"9","author":"M Camilleri","year":"2011","unstructured":"M. Camilleri, A.E. Bharucha, G. Farrugia, Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis. Clin. Gastroenterol. Hepatol. 9, 5\u201312 (2011). https:\/\/doi.org\/10.1016\/j.cgh.2010.09.022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"4693_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/MCG.0000000000001231","volume":"54","author":"AR Syed","year":"2020","unstructured":"A.R. Syed, M.M. Wolfe, J. Calles-Escandon, Epidemiology and Diagnosis of Gastroparesis in the United States: A Population-based Study. J. Clin. Gastroenterol. 54, 50\u201354 (2020). https:\/\/doi.org\/10.1097\/MCG.0000000000001231","journal-title":"J. Clin. Gastroenterol."},{"key":"4693_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1053\/j.gastro.2021.09.064","volume":"162","author":"Y Ye","year":"2022","unstructured":"Y. Ye, Y. Yin, S.Y. Huh et al., Epidemiology, Etiology, and Treatment of Gastroparesis: Real-World Evidence From a Large US National Claims Database. Gastroenterology. 162, 109\u2013121e5 (2022). https:\/\/doi.org\/10.1053\/j.gastro.2021.09.064","journal-title":"Gastroenterology"},{"key":"4693_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/UEG2.12289","volume":"10","author":"IH Huang","year":"2022","unstructured":"I.H. Huang, J. Schol, R. Khatun et al., Worldwide prevalence and burden of gastroparesis-like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. United Eur. Gastroenterol. J. 10, 888\u2013897 (2022). https:\/\/doi.org\/10.1002\/UEG2.12289","journal-title":"United Eur. Gastroenterol. J."},{"key":"4693_CR12","doi-asserted-by":"publisher","first-page":"3827301","DOI":"10.1155\/2018\/3827301","volume":"2018","author":"T Meldgaard","year":"2018","unstructured":"T. Meldgaard, S.S. Olesen, A.D. Farmer et al., Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment. J. Diabetes Res. 2018, 3827301 (2018). https:\/\/doi.org\/10.1155\/2018\/3827301","journal-title":"J. Diabetes Res."},{"key":"4693_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/00365521.2025.2531038","volume":"60","author":"M Bekkelund","year":"2025","unstructured":"M. Bekkelund, E.K. Steinsvik, J. Valeur et al., Key variables associated with gastroparesis in diabetes patients with gastroparesis-like symptoms. Scand. J. Gastroenterol. 60, 865\u2013873 (2025). https:\/\/doi.org\/10.1080\/00365521.2025.2531038","journal-title":"Scand. J. Gastroenterol."},{"key":"4693_CR14","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1053\/J.GASTRO.2025.08.004\/ATTACHMENT\/F1152A5A-1B30-4C2F-8DEE-598E8130010E\/MMC2.PDF","volume":"169","author":"K Staller","year":"2025","unstructured":"K. Staller, H.P. Parkman, K.B. Greer et al., AGA Clinical Practice Guideline on Management of Gastroparesis. Gastroenterology. 169, 828\u2013861 (2025). https:\/\/doi.org\/10.1053\/J.GASTRO.2025.08.004\/ATTACHMENT\/F1152A5A-1B30-4C2F-8DEE-598E8130010E\/MMC2.PDF","journal-title":"Gastroenterology"},{"key":"4693_CR15","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1136\/GUTJNL-2019-318712","volume":"68","author":"M Grover","year":"2019","unstructured":"M. Grover, G. Farrugia, V. Stanghellini, Gastroparesis: a turning point in understanding and treatment. Gut. 68, 2238\u20132250 (2019). https:\/\/doi.org\/10.1136\/GUTJNL-2019-318712","journal-title":"Gut"},{"key":"4693_CR16","doi-asserted-by":"publisher","unstructured":"L. Li, L. Wang, R. Long et al., Prevalence of gastroparesis in diabetic patients: a systematic review and meta-analysis. Sci. Rep. 13 (2023). https:\/\/doi.org\/10.1038\/S41598-023-41112-6","DOI":"10.1038\/S41598-023-41112-6"},{"key":"4693_CR17","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/J.CGH.2018.10.050","volume":"17","author":"HP Parkman","year":"2019","unstructured":"H.P. Parkman, G. Yamada, Van M.L. Natta et al., Ethnic, Racial, and Sex Differences in Etiology, Symptoms, Treatment, and Symptom Outcomes of Patients With Gastroparesis. Clin. Gastroenterol. Hepatol. 17, 1489\u20131499e8 (2019). https:\/\/doi.org\/10.1016\/J.CGH.2018.10.050","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"4693_CR18","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3748\/WJG.V23.I7.1298","volume":"23","author":"S Woodhouse","year":"2017","unstructured":"S. Woodhouse, G. Hebbard, S.R. Knowles, Psychological controversies in gastroparesis: A systematic review. World J. Gastroenterol. 23, 1298\u20131309 (2017). https:\/\/doi.org\/10.3748\/WJG.V23.I7.1298","journal-title":"World J. Gastroenterol."},{"key":"4693_CR19","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1210\/ER.2018-00161","volume":"40","author":"AE Bharucha","year":"2019","unstructured":"A.E. Bharucha, Y.C. Kudva, D.O. Prichard, Diabetic Gastroparesis. Endocr. Rev. 40, 1318\u20131352 (2019). https:\/\/doi.org\/10.1210\/ER.2018-00161","journal-title":"Endocr. Rev."},{"key":"4693_CR20","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1038\/AJG.2010.253","volume":"105","author":"WL Hasler","year":"2010","unstructured":"W.L. Hasler, H.P. Parkman, L.A. Wilson et al., Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am. J. Gastroenterol. 105, 2357\u20132367 (2010). https:\/\/doi.org\/10.1038\/AJG.2010.253","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR21","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/J.GASTRO.2015.08.008","volume":"149","author":"PJ Pasricha","year":"2015","unstructured":"P.J. Pasricha, K.P. Yates, L. Nguyen et al., Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis. Gastroenterology. 149, 1762\u20131774e4 (2015). https:\/\/doi.org\/10.1053\/J.GASTRO.2015.08.008","journal-title":"Gastroenterology"},{"key":"4693_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.DIABRES.2019.06.010","volume":"154","author":"LE Watson","year":"2019","unstructured":"L.E. Watson, L.K. Phillips, T. Wu et al., Longitudinal evaluation of gastric emptying in type 2 diabetes. Diabetes Res. Clin. Pract. 154, 27\u201334 (2019). https:\/\/doi.org\/10.1016\/J.DIABRES.2019.06.010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"4693_CR23","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1056\/NEJMRA2020927\/SUPPL_FILE","volume":"384","author":"RK Goyal","year":"2021","unstructured":"R.K. Goyal, Gastric Emptying Abnormalities in Diabetes Mellitus. N. Engl. J. Med. 384, 1742\u20131751 (2021). https:\/\/doi.org\/10.1056\/NEJMRA2020927\/SUPPL_FILE. http:\/\/NEJMRA2020927_DISCLOSURES.PDF","journal-title":"N. Engl. J. Med."},{"key":"4693_CR24","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1053\/J.GASTRO.2021.01.230","volume":"160","author":"PJ Pasricha","year":"2021","unstructured":"P.J. Pasricha, M. Grover, K.P. Yates et al., Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features. Gastroenterology. 160, 2006\u20132017 (2021). https:\/\/doi.org\/10.1053\/J.GASTRO.2021.01.230","journal-title":"Gastroenterology"},{"key":"4693_CR25","doi-asserted-by":"publisher","unstructured":"S. Uppaluri, M.A. Jain, H. Ali et al., Pathogenesis and management of diabetic gastroparesis: An updated clinically oriented review. Diabetes Metab. Syndr. 18 (2024). https:\/\/doi.org\/10.1016\/J.DSX.2024.102994","DOI":"10.1016\/J.DSX.2024.102994"},{"key":"4693_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6947-7-16\/TABLES\/2","volume":"7","author":"C Schardt","year":"2007","unstructured":"C. Schardt, M.B. Adams, T. Owens et al., Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med. Inf. Decis. Mak. 7, 16\u2013 (2007). https:\/\/doi.org\/10.1186\/1472-6947-7-16\/TABLES\/2","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"4693_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/NMO.12330","volume":"26","author":"SS Yarandi","year":"2014","unstructured":"S.S. Yarandi, S. Srinivasan, Diabetic gastrointestinal motility disorders and the role of enteric nervous system: Current status and future directions. Neurogastroenterology Motil. 26, 611\u2013624 (2014). https:\/\/doi.org\/10.1111\/NMO.12330","journal-title":"Neurogastroenterology Motil."},{"key":"4693_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1590\/S0004-282X2001000100011","volume":"59","author":"CEPT Fregonesi","year":"2001","unstructured":"C.E.P.T. Fregonesi, De M.H. Miranda-Neto, S.L. Molinari, J.N. Zanoni, Quantitative study of the myenteric plexus of the stomach of rats with streptozotocin-induced diabetes. Arq. Neuropsiquiatr. 59, 50\u201353 (2001). https:\/\/doi.org\/10.1590\/S0004-282X2001000100011","journal-title":"Arq. Neuropsiquiatr."},{"key":"4693_CR29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/JNNP.47.7.686","volume":"47","author":"RJC Guy","year":"1984","unstructured":"R.J.C. Guy, J.L. Dawson, J.R. Garrett et al., Diabetic gastroparesis from autonomic neuropathy: surgical considerations and changes in vagus nerve morphology. J. Neurol. Neurosurg. Psychiatry. 47, 686\u2013691 (1984). https:\/\/doi.org\/10.1136\/JNNP.47.7.686","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"4693_CR30","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/JNNP.37.10.1151","volume":"37","author":"B Smith","year":"1974","unstructured":"B. Smith, Neuropathology of the oesophagus in diabetes mellitus. J. Neurol. Neurosurg. Psychiatry. 37, 1151\u20131154 (1974). https:\/\/doi.org\/10.1136\/JNNP.37.10.1151","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"4693_CR31","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2337\/DIACARE.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"A.I. Vinik, R.E. Maser, B.D. Mitchell, R. Freeman, Diabetic Autonomic Neuropathy. Diabetes Care. 26, 1553\u20131579 (2003). https:\/\/doi.org\/10.2337\/DIACARE.26.5.1553","journal-title":"Diabetes Care"},{"key":"4693_CR32","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/J.NEURON.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"E.L. Feldman, K.A. Nave, T.S. Jensen, D.L.H. Bennett, New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron. 93, 1296\u20131313 (2017). https:\/\/doi.org\/10.1016\/J.NEURON.2017.02.005","journal-title":"Neuron"},{"key":"4693_CR33","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1089\/ARS.2005.7.1543","volume":"7","author":"IG Obrosova","year":"2005","unstructured":"I.G. Obrosova, Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid. Redox Signal. 7, 1543\u20131552 (2005). https:\/\/doi.org\/10.1089\/ARS.2005.7.1543","journal-title":"Antioxid. Redox Signal."},{"key":"4693_CR34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/J.EJPHAR.2018.06.034","volume":"833","author":"S Dewanjee","year":"2018","unstructured":"S. Dewanjee, S. Das, A.K. Das et al., Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. Eur. J. Pharmacol. 833, 472\u2013523 (2018). https:\/\/doi.org\/10.1016\/J.EJPHAR.2018.06.034","journal-title":"Eur. J. Pharmacol."},{"key":"4693_CR35","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1172\/JCI111030","volume":"72","author":"DA Greene","year":"1983","unstructured":"D.A. Greene, S.A. Lattimer, Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J. Clin. Invest. 72, 1058\u20131063 (1983). https:\/\/doi.org\/10.1172\/JCI111030","journal-title":"J. Clin. Invest."},{"key":"4693_CR36","doi-asserted-by":"publisher","first-page":"688","DOI":"10.2337\/DIAB.37.6.688","volume":"37","author":"DA Greene","year":"1988","unstructured":"D.A. Greene, S.A. Lattimer, A.A.F. Sima, Are Disturbances of Sorbitol, Phosphoinositide, and Na+-K+-ATPase Regulation Involved in Pathogenesis of Diabetic Neuropathy? Diabetes. 37, 688\u2013693 (1988). https:\/\/doi.org\/10.2337\/DIAB.37.6.688","journal-title":"Diabetes"},{"key":"4693_CR37","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1172\/JCI13038","volume":"107","author":"A Veves","year":"2001","unstructured":"A. Veves, G.L. King, Can VEGF reverse diabetic neuropathy in human subjects? J. Clin. Invest. 107, 1215 (2001). https:\/\/doi.org\/10.1172\/JCI13038","journal-title":"J. Clin. Invest."},{"key":"4693_CR38","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.2337\/DB09-0047","volume":"58","author":"AM Vincent","year":"2009","unstructured":"A.M. Vincent, J.M. Hayes, L.L. McLean et al., Dyslipidemia-induced neuropathy in mice: the role of oxLDL\/LOX-1. Diabetes. 58, 2376\u20132385 (2009). https:\/\/doi.org\/10.2337\/DB09-0047","journal-title":"Diabetes"},{"key":"4693_CR39","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4093\/DMJ.2016.40.4.272","volume":"40","author":"CY Han","year":"2016","unstructured":"C.Y. Han, Roles of Reactive Oxygen Species on Insulin Resistance in Adipose Tissue. Diabetes Metab. J. 40, 272\u2013279 (2016). https:\/\/doi.org\/10.4093\/DMJ.2016.40.4.272","journal-title":"Diabetes Metab. J."},{"key":"4693_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-12-385506-0.00004-1","volume":"98","author":"JG Mielke","year":"2011","unstructured":"J.G. Mielke, Y.T. Wang, Insulin, synaptic function, and opportunities for neuroprotection. Prog Mol. Biol. Transl Sci. 98, 133\u2013186 (2011). https:\/\/doi.org\/10.1016\/B978-0-12-385506-0.00004-1","journal-title":"Prog Mol. Biol. Transl Sci."},{"key":"4693_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/J.TEM.2011.12.004","volume":"23","author":"B Kim","year":"2012","unstructured":"B. Kim, E.L. Feldman, Insulin resistance in the nervous system. Trends Endocrinol. Metab. 23, 133\u2013141 (2012). https:\/\/doi.org\/10.1016\/J.TEM.2011.12.004","journal-title":"Trends Endocrinol. Metab."},{"key":"4693_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/J.GASTRO.2021.10.028","volume":"162","author":"M Camilleri","year":"2022","unstructured":"M. Camilleri, K.M. Sanders, Gastroparesis Gastroenterol. 162, 68\u201387e1 (2022). https:\/\/doi.org\/10.1053\/J.GASTRO.2021.10.028","journal-title":"Gastroparesis Gastroenterol."},{"key":"4693_CR43","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S2468-1253(24)00231-0","volume":"9","author":"A Shin","year":"2024","unstructured":"A. Shin, Disorders of gastric motility. Lancet Gastroenterol. Hepatol. 9, 1052\u20131064 (2024). https:\/\/doi.org\/10.1016\/S2468-1253(24)00231-0","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"4693_CR44","doi-asserted-by":"publisher","first-page":"10131","DOI":"10.3748\/WJG.V22.I46.10131","volume":"22","author":"KS Park","year":"2016","unstructured":"K.S. Park, K.B. Cho, I.S. Hwang et al., Characterization of smooth muscle, enteric nerve, interstitial cells of Cajal, and fibroblast-like cells in the gastric musculature of patients with diabetes mellitus. World J. Gastroenterol. 22, 10131\u201310139 (2016). https:\/\/doi.org\/10.3748\/WJG.V22.I46.10131","journal-title":"World J. Gastroenterol."},{"key":"4693_CR45","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/J.1582-4934.2011.01451.X","volume":"16","author":"MS Faussone-Pellegrini","year":"2012","unstructured":"M.S. Faussone-Pellegrini, M. Grover, P.J. Pasricha et al., Ultrastructural differences between diabetic and idiopathic gastroparesis. J. Cell. Mol. Med. 16, 1573\u20131581 (2012). https:\/\/doi.org\/10.1111\/J.1582-4934.2011.01451.X","journal-title":"J. Cell. Mol. Med."},{"key":"4693_CR46","doi-asserted-by":"publisher","unstructured":"K.L. H\u00f8yer, S.M. Dahl Baunwall, D.S. Kornum et al., (2024) Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trial. EClinicalMedicine 79:. https:\/\/doi.org\/10.1016\/J.ECLINM.2024.103000","DOI":"10.1016\/J.ECLINM.2024.103000"},{"key":"4693_CR47","doi-asserted-by":"publisher","unstructured":"G. Yang, J. Wei, P. Liu et al., Role of the gut microbiota in type 2 diabetes and related diseases. Metabolism. 117 (2021). https:\/\/doi.org\/10.1016\/J.METABOL.2021.154712","DOI":"10.1016\/J.METABOL.2021.154712"},{"key":"4693_CR48","doi-asserted-by":"publisher","unstructured":"W. Tao, Y. Yu, D. Tan et al., Microbiota and enteric nervous system crosstalk in diabetic gastroenteropathy: bridging mechanistic insights to microbiome-based therapies. Front. Cell. Infect. Microbiol. 15 (2025). https:\/\/doi.org\/10.3389\/FCIMB.2025.1603442","DOI":"10.3389\/FCIMB.2025.1603442"},{"key":"4693_CR49","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/S00125-025-06365-Y","volume":"68","author":"DS Kornum","year":"2025","unstructured":"D.S. Kornum, K. Krogh, J. Keller et al., Diabetic gastroenteropathy: a pan-alimentary complication. Diabetologia. 68, 905 (2025). https:\/\/doi.org\/10.1007\/S00125-025-06365-Y","journal-title":"Diabetologia"},{"key":"4693_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS21124540","volume":"21","author":"D Foong","year":"2020","unstructured":"D. Foong, J. Zhou, A. Zarrouk et al., Understanding the Biology of Human Interstitial Cells of Cajal in Gastrointestinal Motility. Int. J. Mol. Sci. 21, 1\u201318 (2020). https:\/\/doi.org\/10.3390\/IJMS21124540","journal-title":"Int. J. Mol. Sci."},{"key":"4693_CR51","doi-asserted-by":"publisher","first-page":"G552","DOI":"10.1152\/AJPGI.00264.2021","volume":"321","author":"JD Huizinga","year":"2021","unstructured":"J.D. Huizinga, A. Hussain, J.H. Chen, Interstitial cells of Cajal and human colon motility in health and disease. Am. J. Physiol. Gastrointest. Liver Physiol. 321, G552\u2013G575 (2021). https:\/\/doi.org\/10.1152\/AJPGI.00264.2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"4693_CR52","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.2337\/DIABETES.54.5.1528","volume":"54","author":"VJ Horv\u00e1th","year":"2005","unstructured":"V.J. Horv\u00e1th, H. Vittal, T. \u00d6rd\u00f6g, Reduced Insulin and IGF-I Signaling, not Hyperglycemia, Underlies the Diabetes-Associated Depletion of Interstitial Cells of Cajal in the Murine Stomach. Diabetes. 54, 1528\u20131533 (2005). https:\/\/doi.org\/10.2337\/DIABETES.54.5.1528","journal-title":"Diabetes"},{"key":"4693_CR53","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1023\/A:1026665728213","volume":"43","author":"I Soykan","year":"1998","unstructured":"I. Soykan, B. Sivri, I. Sarosiek et al., Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig. Dis. Sci. 43, 2398\u20132404 (1998). https:\/\/doi.org\/10.1023\/A:1026665728213","journal-title":"Dig. Dis. Sci."},{"key":"4693_CR54","doi-asserted-by":"publisher","unstructured":"S. Krishnasamy, T.L. Abell, (2018) Diabetic Gastroparesis: Principles and Current Trends in Management. Diabetes Therapy 2018 9:1 9:1\u201342. https:\/\/doi.org\/10.1007\/S13300-018-0454-9","DOI":"10.1007\/S13300-018-0454-9"},{"key":"4693_CR55","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1053\/J.GASTRO.2018.02.027","volume":"154","author":"G Cipriani","year":"2018","unstructured":"G. Cipriani, S.J. Gibbons, K.E. Miller et al., Change in Populations of Macrophages Promotes Development of Delayed Gastric Emptying in Mice. Gastroenterology. 154, 2122\u20132136e12 (2018). https:\/\/doi.org\/10.1053\/J.GASTRO.2018.02.027","journal-title":"Gastroenterology"},{"key":"4693_CR56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/J.1365-2982.2007.01056.X","volume":"20","author":"T \u00d6rd\u00f6g","year":"2008","unstructured":"T. \u00d6rd\u00f6g, Interstitial cells of Cajal in diabetic gastroenteropathy. Neurogastroenterol. Motil. 20, 8\u201318 (2008). https:\/\/doi.org\/10.1111\/J.1365-2982.2007.01056.X","journal-title":"Neurogastroenterol. Motil."},{"key":"4693_CR57","doi-asserted-by":"publisher","unstructured":"K.M. Choi, S.J. Gibbons, T.V. Nguyen et al., Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology. 135 (2008). https:\/\/doi.org\/10.1053\/J.GASTRO.2008.09.003","DOI":"10.1053\/J.GASTRO.2008.09.003"},{"key":"4693_CR58","doi-asserted-by":"publisher","unstructured":"S. Yang, B. Wu, H. Sun et al., Impaired insulin\/IGF-1 is responsible for diabetic gastroparesis by damaging myenteric cholinergic neurones and interstitial cells of Cajal. Biosci. Rep. 37 (2017). https:\/\/doi.org\/10.1042\/BSR20170776","DOI":"10.1042\/BSR20170776"},{"key":"4693_CR59","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1053\/J.GASTRO.2005.12.027","volume":"130","author":"VJ Horv\u00e1th","year":"2006","unstructured":"V.J. Horv\u00e1th, H. Vittal, A. L\u00f6rincz et al., Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology. 130, 759\u2013770 (2006). https:\/\/doi.org\/10.1053\/J.GASTRO.2005.12.027","journal-title":"Gastroenterology"},{"key":"4693_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/NMO.12418","volume":"27","author":"L Neshatian","year":"2015","unstructured":"L. Neshatian, S.J. Gibbons, G. Farrugia, Macrophages in diabetic gastroparesis\u2013the missing link? Neurogastroenterol. Motil. 27, 7\u201318 (2015). https:\/\/doi.org\/10.1111\/NMO.12418","journal-title":"Neurogastroenterol. Motil."},{"key":"4693_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S2468-1253(24)00284-X","volume":"10","author":"J Schol","year":"2025","unstructured":"J. Schol, I.H. Huang, F. Carbone et al., Rome Foundation and international neurogastroenterology and motility societies\u2019 consensus on idiopathic gastroparesis. Lancet Gastroenterol. Hepatol. 10, 68\u201381 (2025). https:\/\/doi.org\/10.1016\/S2468-1253(24)00284-X","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"4693_CR62","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1023\/B:QURE.0000021689.86296.E4","volume":"13","author":"DA Revicki","year":"2004","unstructured":"D.A. Revicki, A.M. Rentz, D. Dubois et al., Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual. Life Res. 13, 833\u2013844 (2004). https:\/\/doi.org\/10.1023\/B:QURE.0000021689.86296.E4","journal-title":"Qual. Life Res."},{"key":"4693_CR63","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/S11136-004-9567-X","volume":"13","author":"AM Rentz","year":"2004","unstructured":"A.M. Rentz, P. Kahrilas, V. Stanghellini et al., Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual. Life Res. 13, 1737\u20131749 (2004). https:\/\/doi.org\/10.1007\/S11136-004-9567-X","journal-title":"Qual. Life Res."},{"key":"4693_CR64","doi-asserted-by":"publisher","unstructured":"M. Petri, I. Singh, C. Baker et al., Diabetic gastroparesis: An overview of pathogenesis, clinical presentation and novel therapies, with a focus on ghrelin receptor agonists. J. Diabetes Complications. 35 (2021). https:\/\/doi.org\/10.1016\/J.JDIACOMP.2020.107733","DOI":"10.1016\/J.JDIACOMP.2020.107733"},{"key":"4693_CR65","doi-asserted-by":"publisher","DOI":"10.14309\/AJG.0000000000003545","author":"K Karrento","year":"2025","unstructured":"K. Karrento, B.P. Chumpitazi, L. Zhang et al., 13\u00a0C-Spirulina Gastric Emptying Breath Test Normative Values in Healthy Children: A Multicenter Study With Comparison to Symptomatic Children. Am. J. Gastroenterol. (2025). https:\/\/doi.org\/10.14309\/AJG.0000000000003545","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR66","doi-asserted-by":"publisher","unstructured":"A.E. Bharucha, M. Camilleri, E. Veil et al., Comprehensive assessment of gastric emptying with a stable isotope breath test. Neurogastroenterol. Motil. 25 (2013). https:\/\/doi.org\/10.1111\/NMO.12054","DOI":"10.1111\/NMO.12054"},{"key":"4693_CR67","doi-asserted-by":"publisher","unstructured":"J. Keller, H.F. Hammer, B. Hauser, 13\u00a0C-gastric emptying breath tests: Clinical use in adults and children. Neurogastroenterol. Motil. 33 (2021). https:\/\/doi.org\/10.1111\/NMO.14172","DOI":"10.1111\/NMO.14172"},{"key":"4693_CR68","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/NMO.12845","volume":"28","author":"B Hauser","year":"2016","unstructured":"B. Hauser, M. Roelants, De J. Schepper et al., Gastric emptying of solids in children: reference values for the (13) C-octanoic acid breath test. Neurogastroenterol. Motil. 28, 1480\u20131487 (2016). https:\/\/doi.org\/10.1111\/NMO.12845","journal-title":"Neurogastroenterol. Motil."},{"key":"4693_CR69","doi-asserted-by":"publisher","unstructured":"L.A. Szarka, M. Camilleri, A. Vella et al., A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin. Gastroenterol. Hepatol. 6 (2008). https:\/\/doi.org\/10.1016\/J.CGH.2008.01.009","DOI":"10.1016\/J.CGH.2008.01.009"},{"key":"4693_CR70","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/J.1572-0241.2002.05664.X","volume":"97","author":"J Romagnuolo","year":"2002","unstructured":"J. Romagnuolo, D. Schiller, R.J. Bailey, Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am. J. Gastroenterol. 97, 1113\u20131126 (2002). https:\/\/doi.org\/10.1111\/J.1572-0241.2002.05664.X","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR71","doi-asserted-by":"publisher","first-page":"395","DOI":"10.5056\/JNM.2013.19.3.395","volume":"19","author":"T Patcharatrakul","year":"2013","unstructured":"T. Patcharatrakul, S. Gonlachanvit, Technique of functional and motility test: how to perform antroduodenal manometry. J. Neurogastroenterol Motil. 19, 395\u2013404 (2013). https:\/\/doi.org\/10.5056\/JNM.2013.19.3.395","journal-title":"J. Neurogastroenterol Motil."},{"key":"4693_CR72","doi-asserted-by":"publisher","unstructured":"L.G. Alcala-Gonzalez, C. Malagelada, C. Galan et al., Propagation patterns of jejunal motor activity measured by high-resolution water-perfused manometry. Neurogastroenterol. Motil. 33 (2021). https:\/\/doi.org\/10.1111\/NMO.14240","DOI":"10.1111\/NMO.14240"},{"key":"4693_CR73","doi-asserted-by":"publisher","first-page":"G16","DOI":"10.1152\/AJPGI.00101.2023","volume":"326","author":"H Soliman","year":"2024","unstructured":"H. Soliman, F. Wuestenberghs, C. Desprez et al., Physiological characterization of gastric emptying using high-resolution antropyloroduodenal manometry. Am. J. Physiol. Gastrointest. Liver Physiol. 326, G16\u2013G24 (2024). https:\/\/doi.org\/10.1152\/AJPGI.00101.2023","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"4693_CR74","doi-asserted-by":"publisher","first-page":"G255","DOI":"10.1152\/AJPGI.00119.2022","volume":"323","author":"T Zheng","year":"2022","unstructured":"T. Zheng, J. BouSaba, W. Sannaa et al., Comprehensive characterization of antral and pyloric contractions by high resolution manometry: applied physiology in suspected gastroparesis. Am. J. Physiol. Gastrointest. Liver Physiol. 323, G255\u2013G264 (2022). https:\/\/doi.org\/10.1152\/AJPGI.00119.2022","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"4693_CR75","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/J.1572-0241.1998.00334.X","volume":"93","author":"S Weston","year":"1998","unstructured":"S. Weston, M. Thumshirn, J. Wiste, M. Camilleri, Clinical and Upper Gastrointestinal Motility Features in Systemic Sclerosis and Related Disorders. Am. J. Gastroenterol. 93, 1085\u20131089 (1998). https:\/\/doi.org\/10.1111\/J.1572-0241.1998.00334.X","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11894-016-0489-X","volume":"18","author":"RJ Saad","year":"2016","unstructured":"R.J. Saad, The Wireless Motility Capsule: a One-Stop Shop for the Evaluation of GI Motility Disorders. Curr. Gastroenterol. Rep. 18, 1\u20137 (2016). https:\/\/doi.org\/10.1007\/S11894-016-0489-X","journal-title":"Curr. Gastroenterol. Rep."},{"key":"4693_CR77","doi-asserted-by":"publisher","first-page":"265","DOI":"10.5056\/JNM.2014.20.2.265","volume":"20","author":"YY Lee","year":"2014","unstructured":"Y.Y. Lee, A. Erdogan, S.S.C. Rao, How to assess regional and whole gut transit time with wireless motility capsule. J. Neurogastroenterol Motil. 20, 265\u2013270 (2014). https:\/\/doi.org\/10.5056\/JNM.2014.20.2.265","journal-title":"J. Neurogastroenterol Motil."},{"key":"4693_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/NMO.13107","volume":"29","author":"HO Diaz Tartera","year":"2017","unstructured":"H.O. Diaz Tartera, D.L. Webb, A.K. Al-Saffar et al., Validation of SmartPill\u00ae wireless motility capsule for gastrointestinal transit time: Intra-subject variability, software accuracy and comparison with video capsule endoscopy. Neurogastroenterol. Motil. 29, 1\u20139 (2017). https:\/\/doi.org\/10.1111\/NMO.13107","journal-title":"Neurogastroenterol. Motil."},{"key":"4693_CR79","doi-asserted-by":"publisher","unstructured":"L. Rodriguez, N. Heinz, K. Colliard et al., Diagnostic and clinical utility of the wireless motility capsule in children: A study in patients with functional gastrointestinal disorders. Neurogastroenterol. Motil. 33 (2021). https:\/\/doi.org\/10.1111\/NMO.14032","DOI":"10.1111\/NMO.14032"},{"key":"4693_CR80","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1111\/J.1572-0241.1999.01429.X","volume":"94","author":"L Benini","year":"1999","unstructured":"L. Benini, C. Sembenini, R.C. Heading et al., Simultaneous measurement of gastric emptying of a solid meal by ultrasound and by scintigraphy. Am. J. Gastroenterol. 94, 2861\u20132865 (1999). https:\/\/doi.org\/10.1111\/J.1572-0241.1999.01429.X","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR81","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/ALN.0B013E3181A97250","volume":"111","author":"A Perlas","year":"2009","unstructured":"A. Perlas, V.W.S. Chan, C.M. Lupu et al., Ultrasound assessment of gastric content and volume. Anesthesiology. 111, 82\u201389 (2009). https:\/\/doi.org\/10.1097\/ALN.0B013E3181A97250","journal-title":"Anesthesiology"},{"key":"4693_CR82","doi-asserted-by":"publisher","unstructured":"E.K. Steinsvik, D.A. Sangnes, E. S\u00f8fteland et al., Gastric function in diabetic gastroparesis assessed by ultrasound and scintigraphy. Neurogastroenterol. Motil. 34 (2022). https:\/\/doi.org\/10.1111\/NMO.14235","DOI":"10.1111\/NMO.14235"},{"key":"4693_CR83","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/S10620-024-08727-9","volume":"70","author":"JJ Peralta-Palmezano","year":"2025","unstructured":"J.J. Peralta-Palmezano, D.P. Escobar-Serna, F.J. Peralta-Palmezano et al., Electrogastrography in Adult Gastroparesis: A Systematic Review and Meta-Analysis. Dig. Dis. Sci. 70, 298\u2013315 (2025). https:\/\/doi.org\/10.1007\/S10620-024-08727-9","journal-title":"Dig. Dis. Sci."},{"key":"4693_CR84","doi-asserted-by":"publisher","unstructured":"D.A. Carson, G. O\u2019Grady, P. Du et al., Body surface mapping of the stomach: New directions for clinically evaluating gastric electrical activity. Neurogastroenterol. Motil. 33 (2021). https:\/\/doi.org\/10.1111\/NMO.14048","DOI":"10.1111\/NMO.14048"},{"key":"4693_CR85","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/09544119231212269","volume":"238","author":"A Al Kafee","year":"2024","unstructured":"A. Al Kafee, Y. Kayar, Electrogastrography in patients with gastric motility disorders. Proc. Inst. Mech. Eng. H. 238, 22\u201332 (2024). https:\/\/doi.org\/10.1177\/09544119231212269","journal-title":"Proc. Inst. Mech. Eng. H"},{"key":"4693_CR86","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1109\/TBME.2022.3167338","volume":"69","author":"AS Agrusa","year":"2022","unstructured":"A.S. Agrusa, D.C. Kunkel, T.P. Coleman, Robust Regression and Optimal Transport Methods to Predict Gastrointestinal Disease Etiology From High Resolution EGG and Symptom Severity. IEEE Trans. Biomed. Eng. 69, 3313\u20133325 (2022). https:\/\/doi.org\/10.1109\/TBME.2022.3167338","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"4693_CR87","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1148\/RG.220052","volume":"42","author":"AK Nehra","year":"2022","unstructured":"A.K. Nehra, S.P. Sheedy, C.D. Johnson et al., Imaging Review of Gastrointestinal Motility Disorders. Radiographics. 42, 2014\u20132036 (2022). https:\/\/doi.org\/10.1148\/RG.220052","journal-title":"Radiographics"},{"key":"4693_CR88","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.3748\/WJG.V30.I22.2852","volume":"30","author":"M Mohamed","year":"2024","unstructured":"M. Mohamed, I. Abdalla, Enteric neuropathy in diabetes: Implications for gastrointestinal function. World J. Gastroenterol. 30, 2852\u20132865 (2024). https:\/\/doi.org\/10.3748\/WJG.V30.I22.2852","journal-title":"World J. Gastroenterol."},{"key":"4693_CR89","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/GUT.2009.199703","volume":"59","author":"P Kashyap","year":"2010","unstructured":"P. Kashyap, G. Farrugia, Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut. 59, 1716\u20131726 (2010). https:\/\/doi.org\/10.1136\/GUT.2009.199703","journal-title":"Gut"},{"key":"4693_CR90","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2337\/DIAB.36.10.1167","volume":"36","author":"J Calles-Escandon","year":"1987","unstructured":"J. Calles-Escandon, D.C. Robbins, Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes. 36, 1167\u20131172 (1987). https:\/\/doi.org\/10.2337\/DIAB.36.10.1167","journal-title":"Diabetes"},{"key":"4693_CR91","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1210\/JC.2017-02811","volume":"103","author":"R Lupoli","year":"2018","unstructured":"R. Lupoli, A. Creanza, E. Griffo et al., Gastric Emptying Impacts the Timing of Meal Glucose Peak in Subjects With Uncomplicated Type 1 Diabetes. J. Clin. Endocrinol. Metab. 103, 2269\u20132276 (2018). https:\/\/doi.org\/10.1210\/JC.2017-02811","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4693_CR92","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/S00125-022-05796-1","volume":"65","author":"RJ Jalleh","year":"2022","unstructured":"R.J. Jalleh, K.L. Jones, C.K. Rayner et al., Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control. Diabetologia. 65, 1981\u20131993 (2022). https:\/\/doi.org\/10.1007\/S00125-022-05796-1","journal-title":"Diabetologia"},{"key":"4693_CR93","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/NRENDO.2014.202","volume":"11","author":"LK Phillips","year":"2015","unstructured":"L.K. Phillips, A.M. Deane, K.L. Jones et al., Gastric emptying and glycaemia in health and diabetes mellitus. Nat. Rev. Endocrinol. 11, 112\u2013128 (2015). https:\/\/doi.org\/10.1038\/NRENDO.2014.202","journal-title":"Nat. Rev. Endocrinol."},{"key":"4693_CR94","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/J.1463-1326.2012.01580.X","volume":"14","author":"PD Home","year":"2012","unstructured":"P.D. Home, The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences. Diabetes Obes. Metab. 14, 780\u2013788 (2012). https:\/\/doi.org\/10.1111\/J.1463-1326.2012.01580.X","journal-title":"Diabetes Obes. Metab."},{"key":"4693_CR95","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/BF00400362","volume":"36","author":"M Horowitz","year":"1993","unstructured":"M. Horowitz, M.A.L. Edelbroek, J.M. Wishart, J.W. Straathof, Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia. 36, 857\u2013862 (1993). https:\/\/doi.org\/10.1007\/BF00400362","journal-title":"Diabetologia"},{"key":"4693_CR96","doi-asserted-by":"publisher","unstructured":"B.M. Mihai, C. Mihai, C. Cijevschi-Prelipcean et al., (2018) Bidirectional Relationship between Gastric Emptying and Plasma Glucose Control in Normoglycemic Individuals and Diabetic Patients. J Diabetes Res 2018:. https:\/\/doi.org\/10.1155\/2018\/1736959","DOI":"10.1155\/2018\/1736959"},{"key":"4693_CR97","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/S41395-018-0234-1","volume":"114","author":"V Chedid","year":"2019","unstructured":"V. Chedid, J. Brandler, P. Vijayvargiya et al., Characterization of Upper Gastrointestinal Symptoms, Gastric Motor Functions, and Associations in Patients with Diabetes at a Referral Center. Am. J. Gastroenterol. 114, 143\u2013154 (2019). https:\/\/doi.org\/10.1038\/S41395-018-0234-1","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR98","doi-asserted-by":"publisher","unstructured":"E.S. Scott, A.S. Januszewski, R. O\u2019Connell et al., Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study. J. Clin. Endocrinol. Metab. 105 (2020). https:\/\/doi.org\/10.1210\/CLINEM\/DGAA361","DOI":"10.1210\/CLINEM\/DGAA361"},{"key":"4693_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/J.DIABRES.2022.110085","author":"J Chen","year":"2022","unstructured":"J. Chen, Q. Yi, Y. Wang et al., Long-term glycemic variability and risk of adverse health outcomes in patients with diabetes: A systematic review and meta-analysis of cohort studies. Diabetes Res. Clin. Pract. (2022). https:\/\/doi.org\/10.1016\/J.DIABRES.2022.110085. 192:","journal-title":"Diabetes Res. Clin. Pract."},{"key":"4693_CR100","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/S12933-020-01200-7","volume":"20","author":"B Sun","year":"2021","unstructured":"B. Sun, Z. Luo, J. Zhou, Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc. Diabetol. 20, 9 (2021). https:\/\/doi.org\/10.1186\/S12933-020-01200-7","journal-title":"Cardiovasc. Diabetol."},{"key":"4693_CR101","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","volume":"7","author":"A Ceriello","year":"2019","unstructured":"A. Ceriello, L. Monnier, D. Owens, Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 7, 221\u2013230 (2019). https:\/\/doi.org\/10.1016\/S2213-8587(18)30136-0","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4693_CR102","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2169\/INTERNALMEDICINE.8424-21","volume":"61","author":"Y Kusunoki","year":"2022","unstructured":"Y. Kusunoki, K. Konishi, T. Tsunoda, H. Koyama, Significance of Glycemic Variability in Diabetes Mellitus. Intern. Med. 61, 281\u2013290 (2022). https:\/\/doi.org\/10.2169\/INTERNALMEDICINE.8424-21","journal-title":"Intern. Med."},{"key":"4693_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S13300-018-0454-9","volume":"9","author":"S Krishnasamy","year":"2018","unstructured":"S. Krishnasamy, T.L. Abell, Diabetic Gastroparesis: Principles and Current Trends in Management. Diabetes Therapy. 9, 1 (2018). https:\/\/doi.org\/10.1007\/S13300-018-0454-9","journal-title":"Diabetes Therapy"},{"key":"4693_CR104","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/GIDISORD6010016","volume":"6","author":"A Caturano","year":"2024","unstructured":"A. Caturano, M. Cavallo, D. Nilo et al., Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions. Gastrointest. Disorders 2024. 6, 214\u2013229 (2024). https:\/\/doi.org\/10.3390\/GIDISORD6010016","journal-title":"Gastrointest. Disorders 2024"},{"key":"4693_CR105","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S2468-1253(20)30078-9","volume":"5","author":"BN Limketkai","year":"2020","unstructured":"B.N. Limketkai, W. LeBrett, L. Lin, N.D. Shah, Nutritional approaches for gastroparesis. Lancet Gastroenterol. Hepatol. 5, 1017\u20131026 (2020). https:\/\/doi.org\/10.1016\/S2468-1253(20)30078-9","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"4693_CR106","doi-asserted-by":"publisher","unstructured":"H.P. Parkman, K.P. Yates, W.L. Hasler et al., (2011) Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis. Gastroenterology 141:. https:\/\/doi.org\/10.1053\/J.GASTRO.2011.04.045","DOI":"10.1053\/J.GASTRO.2011.04.045"},{"key":"4693_CR107","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/MCO.0000000000000856","volume":"25","author":"A Aguilar","year":"2022","unstructured":"A. Aguilar, C. Malagelada, J. Serra, Nutritional challenges in patients with gastroparesis. Curr. Opin. Clin. Nutr. Metab. Care. 25, 360\u2013363 (2022). https:\/\/doi.org\/10.1097\/MCO.0000000000000856","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"4693_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/S11894-025-00974-8","author":"F Kasem","year":"2025","unstructured":"F. Kasem, A. Franz, E. Omer, Gastroparesis and its Nutritional Implications. Curr. Gastroenterol. Rep. (2025). https:\/\/doi.org\/10.1007\/S11894-025-00974-8. 27:","journal-title":"Curr. Gastroenterol. Rep."},{"key":"4693_CR109","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/J.1464-5491.2004.01132.X","volume":"21","author":"G Schernthaner","year":"2004","unstructured":"G. Schernthaner, W. Wein, N. Shnawa et al., Preprandial vs. postprandial insulin lispro-a comparative crossover trial in patients with Type 1 diabetes. Diabet. Med. 21, 279\u2013284 (2004). https:\/\/doi.org\/10.1111\/J.1464-5491.2004.01132.X","journal-title":"Diabet. Med."},{"key":"4693_CR110","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/DME.13525","volume":"35","author":"D Slattery","year":"2018","unstructured":"D. Slattery, S.A. Amiel, P. Choudhary, Optimal prandial timing of bolus insulin in diabetes management: a review. Diabet. Med. 35, 306\u2013316 (2018). https:\/\/doi.org\/10.1111\/DME.13525","journal-title":"Diabet. Med."},{"key":"4693_CR111","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/DOM.13570","volume":"21","author":"CS Marathe","year":"2019","unstructured":"C.S. Marathe, J.A. Marathe, C.K. Rayner et al., Hypoglycaemia and gastric emptying. Diabetes Obes. Metab. 21, 491\u2013498 (2019). https:\/\/doi.org\/10.1111\/DOM.13570","journal-title":"Diabetes Obes. Metab."},{"key":"4693_CR112","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/J.GTC.2014.11.005","volume":"44","author":"KL Koch","year":"2015","unstructured":"K.L. Koch, J. Calles-Escand\u00f3n, Diabetic gastroparesis. Gastroenterol. Clin. North. Am. 44, 39\u201357 (2015). https:\/\/doi.org\/10.1016\/J.GTC.2014.11.005","journal-title":"Gastroenterol. Clin. North. Am."},{"key":"4693_CR113","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1089\/152091502320798312","volume":"4","author":"L Heinemann","year":"2002","unstructured":"L. Heinemann, Variability of insulin absorption and insulin action. Diabetes Technol. Ther. 4, 673\u2013682 (2002). https:\/\/doi.org\/10.1089\/152091502320798312","journal-title":"Diabetes Technol. Ther."},{"key":"4693_CR114","doi-asserted-by":"publisher","first-page":"01","DOI":"10.51611\/iars.irj.v11i2.2021.134","volume":"11","author":"R korivi","year":"2021","unstructured":"R. korivi, R. korivi, B.R. Krishna, A Study on Assessment and Management of Diabetic Gastropathy. IARS\u2019 Int. Res. J. 11, 01\u201305 (2021). https:\/\/doi.org\/10.51611\/iars.irj.v11i2.2021.134","journal-title":"IARS\u2019 Int. Res. J."},{"key":"4693_CR115","doi-asserted-by":"publisher","unstructured":"D. Lin, H. Wang, Y. Ou et al., The role of diet in diabetes gastroparesis treatment: a systematic review and meta-analysis. Front. Endocrinol. (Lausanne). 15 (2024). https:\/\/doi.org\/10.3389\/FENDO.2024.1379398","DOI":"10.3389\/FENDO.2024.1379398"},{"key":"4693_CR116","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/ADVANCES\/NMAC037","volume":"13","author":"D Eseonu","year":"2022","unstructured":"D. Eseonu, T. Su, K. Lee et al., Dietary Interventions for Gastroparesis: A Systematic Review. Adv. Nutr. 13, 1715\u20131724 (2022). https:\/\/doi.org\/10.1093\/ADVANCES\/NMAC037","journal-title":"Adv. Nutr."},{"key":"4693_CR117","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/S40200-022-01117-W","volume":"21","author":"CC Bet\u00f4nico","year":"2022","unstructured":"C.C. Bet\u00f4nico, A.V. Cobello, D.P. Santos-Bezerra et al., Diet consistency modification improves postprandial glycemic and gastroparesis symptoms. J. Diabetes Metab. Disord. 21, 1661\u20131667 (2022). https:\/\/doi.org\/10.1007\/S40200-022-01117-W","journal-title":"J. Diabetes Metab. Disord"},{"key":"4693_CR118","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/AJG.2013.453","volume":"109","author":"EA Olausson","year":"2014","unstructured":"E.A. Olausson, S. St\u00f6rsrud, H. Grundin et al., A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am. J. Gastroenterol. 109, 375\u2013385 (2014). https:\/\/doi.org\/10.1038\/AJG.2013.453","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR119","doi-asserted-by":"publisher","unstructured":"S. Bonetto, G. Gruden, G. Beccuti et al., Management of Dyspepsia and Gastroparesis in Patients with Diabetes. A Clinical Point of View in the Year 2021. J. Clin. Med. 10 (2021). https:\/\/doi.org\/10.3390\/JCM10061313","DOI":"10.3390\/JCM10061313"},{"key":"4693_CR120","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/J.PHARMR.2024.100019","volume":"77","author":"M Camilleri","year":"2024","unstructured":"M. Camilleri, K.J. Jencks, Pharmacologic treatments for gastroparesis. Pharmacol. Rev. 77, 100019 (2024). https:\/\/doi.org\/10.1016\/J.PHARMR.2024.100019","journal-title":"Pharmacol. Rev."},{"key":"4693_CR121","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/17474124.2019.1645594","volume":"13","author":"M Shakhatreh","year":"2019","unstructured":"M. Shakhatreh, A. Jehangir, Z. Malik, H.P. Parkman, Metoclopramide for the treatment of diabetic gastroparesis. Expert Rev. Gastroenterol. Hepatol. 13, 711\u2013721 (2019). https:\/\/doi.org\/10.1080\/17474124.2019.1645594","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"4693_CR122","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/NMO.12296","volume":"26","author":"HP Parkman","year":"2014","unstructured":"H.P. Parkman, M.R. Carlson, D. Gonyer, Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet. Neurogastroenterology Motil. 26, 521\u2013528 (2014). https:\/\/doi.org\/10.1111\/NMO.12296","journal-title":"Neurogastroenterology Motil."},{"key":"4693_CR123","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1111\/J.1572-0241.2007.01255.X","volume":"102","author":"SC Reddymasu","year":"2007","unstructured":"S.C. Reddymasu, I. Soykan, R.W. McCallum, Domperidone: review of pharmacology and clinical applications in gastroenterology. Am. J. Gastroenterol. 102, 2036\u20132045 (2007). https:\/\/doi.org\/10.1111\/J.1572-0241.2007.01255.X","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR124","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1053\/J.GASTRO.2022.12.014","volume":"164","author":"MR Ingrosso","year":"2023","unstructured":"M.R. Ingrosso, M. Camilleri, J. Tack et al., Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis. Gastroenterology. 164, 642\u2013654 (2023). https:\/\/doi.org\/10.1053\/J.GASTRO.2022.12.014","journal-title":"Gastroenterology"},{"key":"4693_CR125","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.14309\/AJG.0000000000000304","volume":"114","author":"F Carbone","year":"2019","unstructured":"F. Carbone, Van Den K. Houte, E. Clevers et al., Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study. Am. J. Gastroenterol. 114, 1265\u20131274 (2019). https:\/\/doi.org\/10.14309\/AJG.0000000000000304","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR126","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/J.MAYOCP.2025.09.017","volume":"100","author":"B Saha","year":"2025","unstructured":"B. Saha, V. Kamalumpundi, D.C. Codipilly, GLP1 and GIP Receptor Agonists: Effects on the Gastrointestinal Tract and Management Strategies for Primary Care Physicians. Mayo Clin. Proc. 100, 2228\u20132236 (2025). https:\/\/doi.org\/10.1016\/J.MAYOCP.2025.09.017","journal-title":"Mayo Clin. Proc."},{"key":"4693_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/CLINEM\/DGAE719","volume":"110","author":"RJ Jalleh","year":"2024","unstructured":"R.J. Jalleh, M.P. Plummer, C.S. Marathe et al., Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. J. Clin. Endocrinol. Metab. 110, 1\u201315 (2024). https:\/\/doi.org\/10.1210\/CLINEM\/DGAE719","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4693_CR128","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2337\/DIACARE.27.5.1071","volume":"27","author":"Z Lin","year":"2004","unstructured":"Z. Lin, J. Forster, I. Sarosiek, R.W. McCallum, Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation. Diabetes Care. 27, 1071\u20131076 (2004). https:\/\/doi.org\/10.2337\/DIACARE.27.5.1071","journal-title":"Diabetes Care"},{"key":"4693_CR129","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/GUTJNL-2020-322756","volume":"71","author":"K Vosoughi","year":"2022","unstructured":"K. Vosoughi, Y. Ichkhanian, P. Benias et al., Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut. 71, 25\u201333 (2022). https:\/\/doi.org\/10.1136\/GUTJNL-2020-322756","journal-title":"Gut"},{"key":"4693_CR130","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000002279","author":"S Khan","year":"2025","unstructured":"S. Khan, M. Shafiq, M.A. Khan et al., Short-term and Long-term Efficacy of Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Meta-analysis. J. Clin. Gastroenterol. (2025). https:\/\/doi.org\/10.1097\/MCG.0000000000002279","journal-title":"J. Clin. Gastroenterol."},{"key":"4693_CR131","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.2337\/DCI22-0018","volume":"45","author":"JL Sherr","year":"2022","unstructured":"J.L. Sherr, L. Heinemann, G.A. Fleming et al., Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetes Care. 45, 3058\u20133074 (2022). https:\/\/doi.org\/10.2337\/DCI22-0018","journal-title":"Diabetes Care"},{"key":"4693_CR132","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.2337\/DC25-S007","volume":"48","author":"ADAPP Committee","year":"2025","unstructured":"A.D.A.P.P. Committee, N.A. ElSayed, R.G. McCoy et al., 7. Diabetes Technology: Standards of Care in Diabetes\u20142025. Diabetes Care. 48, S146\u2013S166 (2025). https:\/\/doi.org\/10.2337\/DC25-S007","journal-title":"Diabetes Care"},{"key":"4693_CR133","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/DC17-1600","volume":"40","author":"T Danne","year":"2017","unstructured":"T. Danne, R. Nimri, T. Battelino et al., International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 40, 1631\u20131640 (2017). https:\/\/doi.org\/10.2337\/DC17-1600","journal-title":"Diabetes Care"},{"key":"4693_CR134","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/DMRR.2557","volume":"31","author":"A Tumminia","year":"2015","unstructured":"A. Tumminia, S. Crimi, L. Sciacca et al., Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial. Diabetes Metab. Res. Rev. 31, 61\u201368 (2015). https:\/\/doi.org\/10.1002\/DMRR.2557","journal-title":"Diabetes Metab. Res. Rev."},{"key":"4693_CR135","doi-asserted-by":"publisher","unstructured":"J. Calles-Escand\u00f3n, K.L. Koch, W.L. Hasler et al., Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study. PLoS One. 13 (2018). https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0194759","DOI":"10.1371\/JOURNAL.PONE.0194759"},{"key":"4693_CR136","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1007\/S00125-011-2282-6","volume":"54","author":"D Sharma","year":"2011","unstructured":"D. Sharma, G. Morrison, F. Joseph et al., The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis. Diabetologia. 54, 2768\u20132770 (2011). https:\/\/doi.org\/10.1007\/S00125-011-2282-6","journal-title":"Diabetologia"},{"key":"4693_CR137","doi-asserted-by":"publisher","unstructured":"C. Bender, P. Vestergaard, S.L. Cichosz, (2025) The History, Evolution and Future of Continuous Glucose Monitoring (CGM). Diabetology 2025, Vol 6, Page 17 6:17. https:\/\/doi.org\/10.3390\/DIABETOLOGY6030017","DOI":"10.3390\/DIABETOLOGY6030017"},{"key":"4693_CR138","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1056\/NEJMRA2215899","volume":"389","author":"MS Hughes","year":"2023","unstructured":"M.S. Hughes, A. Addala, B. Buckingham, Digital Technology for Diabetes. N Engl. J. Med. 389, 2076\u20132086 (2023). https:\/\/doi.org\/10.1056\/NEJMRA2215899","journal-title":"N Engl. J. Med."},{"key":"4693_CR139","doi-asserted-by":"publisher","unstructured":"A. Tumminia, G.M. Santoro, V. Oteri et al., The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy. Diabetes Res. Clin. Pract. 224 (2025). https:\/\/doi.org\/10.1016\/J.DIABRES.2025.112173","DOI":"10.1016\/J.DIABRES.2025.112173"},{"key":"4693_CR140","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","volume":"11","author":"T Battelino","year":"2023","unstructured":"T. Battelino, C.M. Alexander, S.A. Amiel et al., Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 11, 42\u201357 (2023). https:\/\/doi.org\/10.1016\/S2213-8587(22)00319-9","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4693_CR141","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.2337\/DC25-S006","volume":"48","author":"ADAPP Committee","year":"2025","unstructured":"A.D.A.P.P. Committee, N.A. ElSayed, R.G. McCoy et al., 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes\u20142025. Diabetes Care. 48, S128\u2013S145 (2025). https:\/\/doi.org\/10.2337\/DC25-S006","journal-title":"Diabetes Care"},{"key":"4693_CR142","doi-asserted-by":"publisher","unstructured":"R.M. Bergenstal, T.W. Martens, R.W. Beck, (2025) Continuous Glucose Monitoring. JAMA. https:\/\/doi.org\/10.1001\/JAMA.2025.19197","DOI":"10.1001\/JAMA.2025.19197"},{"key":"4693_CR143","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/DME.13944","volume":"36","author":"SA Brown","year":"2019","unstructured":"S.A. Brown, A. Basu, B.P. Kovatchev, Beyond HbA1c: using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision-making. Diabet. Med. 36, 679\u2013687 (2019). https:\/\/doi.org\/10.1111\/DME.13944","journal-title":"Diabet. Med."},{"key":"4693_CR144","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0140-6736(19)31142-0","volume":"394","author":"RW Beck","year":"2019","unstructured":"R.W. Beck, R.M. Bergenstal, L.M. Laffel, J.C. Pickup, Advances in technology for management of type 1 diabetes. Lancet. 394, 1265\u20131273 (2019). https:\/\/doi.org\/10.1016\/S0140-6736(19)31142-0","journal-title":"Lancet"},{"key":"4693_CR145","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1177\/19322968211015206","volume":"16","author":"SL Cichosz","year":"2021","unstructured":"S.L. Cichosz, O. Hejlesen, Classification of Gastroparesis from Glycemic Variability in Type 1 Diabetes: A Proof-of-Concept Study. J. Diabetes Sci. Technol. 16, 1190 (2021). https:\/\/doi.org\/10.1177\/19322968211015206","journal-title":"J. Diabetes Sci. Technol."},{"key":"4693_CR146","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1007\/S10620-011-1810-Z","volume":"56","author":"Z Ramzan","year":"2011","unstructured":"Z. Ramzan, F. Duffy, J. Gomez et al., Continuous glucose monitoring in gastroparesis. Dig. Dis. Sci. 56, 2646\u20132655 (2011). https:\/\/doi.org\/10.1007\/S10620-011-1810-Z","journal-title":"Dig. Dis. Sci."},{"key":"4693_CR147","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1186\/S12876-025-03977-X","volume":"25","author":"M-N Wifi","year":"2025","unstructured":"M.-N. Wifi, M. El-Sherbiny, R.S. Mohamed et al., Clinical insights into diabetic gastroparesis: gastric scintigraphy-based diagnosis and treatment outcomes. BMC Gastroenterol. 25, 640 (2025). https:\/\/doi.org\/10.1186\/S12876-025-03977-X","journal-title":"BMC Gastroenterol."},{"key":"4693_CR148","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1177\/193229680900300631","volume":"3","author":"L Heinemann","year":"2009","unstructured":"L. Heinemann, Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements? J. Diabetes Sci. Technol. 3, 1490\u20131500 (2009). https:\/\/doi.org\/10.1177\/193229680900300631","journal-title":"J. Diabetes Sci. Technol."},{"key":"4693_CR149","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/J.1399-5448.2008.00471.X","volume":"10","author":"E Pa\u0144kowska","year":"2009","unstructured":"E. Pa\u0144kowska, A. Szypowska, M. Lipka et al., Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes. Pediatr. Diabetes. 10, 298\u2013303 (2009). https:\/\/doi.org\/10.1111\/J.1399-5448.2008.00471.X","journal-title":"Pediatr. Diabetes"},{"key":"4693_CR150","doi-asserted-by":"publisher","unstructured":"M. Metwally, T.O. Cheung, R. Smith, K.J. Bell, Insulin pump dosing strategies for meals varying in fat, protein or glycaemic index or grazing-style meals in type 1 diabetes: A systematic review. Diabetes Res. Clin. Pract. 172 (2021). https:\/\/doi.org\/10.1016\/J.DIABRES.2020.108516","DOI":"10.1016\/J.DIABRES.2020.108516"},{"key":"4693_CR151","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/J.1464-5491.2002.00685.X","volume":"19","author":"HP Chase","year":"2002","unstructured":"H.P. Chase, S.Z. Saib, T. MacKenzie et al., Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes. Diabet. Med. 19, 317\u2013321 (2002). https:\/\/doi.org\/10.1046\/J.1464-5491.2002.00685.X","journal-title":"Diabet. Med."},{"key":"4693_CR152","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2147\/PPA.S69482","volume":"9","author":"A Tumminia","year":"2015","unstructured":"A. Tumminia, L. Sciacca, L. Frittitta et al., Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update. Patient Prefer Adherence. 9, 1263\u20131270 (2015). https:\/\/doi.org\/10.2147\/PPA.S69482","journal-title":"Patient Prefer Adherence"},{"key":"4693_CR153","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1177\/19322968211035447","volume":"15","author":"A Daly","year":"2021","unstructured":"A. Daly, S. Hartnell, C.K. Boughton, M. Evans, Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series. J. Diabetes Sci. Technol. 15, 1216\u20131223 (2021). https:\/\/doi.org\/10.1177\/19322968211035447","journal-title":"J. Diabetes Sci. Technol."},{"key":"4693_CR154","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1089\/DIA.2019.0254","volume":"21","author":"H Kaur","year":"2019","unstructured":"H. Kaur, N. Schneider, L. Pyle et al., Efficacy of Hybrid Closed-Loop System in Adults with Type 1 Diabetes and Gastroparesis. Diabetes Technol. Ther. 21, 736\u2013739 (2019). https:\/\/doi.org\/10.1089\/DIA.2019.0254","journal-title":"Diabetes Technol. Ther."},{"key":"4693_CR155","doi-asserted-by":"publisher","unstructured":"J. Jendle, Y. Reznik, Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers. Diabetes Obes. Metab. 25 Suppl. 221\u201332 (2023). https:\/\/doi.org\/10.1111\/DOM.15087","DOI":"10.1111\/DOM.15087"},{"key":"4693_CR156","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/DCI19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"T. Battelino, T. Danne, R.M. Bergenstal et al., Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 42, 1593\u20131603 (2019). https:\/\/doi.org\/10.2337\/DCI19-0028","journal-title":"Diabetes Care"},{"key":"4693_CR157","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/PEDI.12737","volume":"27","author":"LA DiMeglio","year":"2018","unstructured":"L.A. DiMeglio, C.L. Acerini, E. Codner et al., ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr. Diabetes 19 Suppl. 27, 105\u2013114 (2018). https:\/\/doi.org\/10.1111\/PEDI.12737","journal-title":"Pediatr. Diabetes 19 Suppl."},{"key":"4693_CR158","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/DOM.13052","volume":"20","author":"V Gingras","year":"2018","unstructured":"V. Gingras, N. Taleb, A. Roy-Fleming et al., The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes. Diabetes Obes. Metab. 20, 245\u2013256 (2018). https:\/\/doi.org\/10.1111\/DOM.13052","journal-title":"Diabetes Obes. Metab."},{"key":"4693_CR159","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/DOM.15463","volume":"26","author":"A Jafar","year":"2024","unstructured":"A. Jafar, M.R. Pasqua, Postprandial glucose-management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligence. Diabetes Obes. Metab. 26, 1555\u20131566 (2024). https:\/\/doi.org\/10.1111\/DOM.15463","journal-title":"Diabetes Obes. Metab."},{"key":"4693_CR160","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1056\/nejmc2315000","volume":"390","author":"B Kinny-K\u00f6ster","year":"2024","unstructured":"B. Kinny-K\u00f6ster, C.W. Michalski, M. Loos, Digital Technology for Diabetes. N. Engl. J. Med. 390, 962\u2013964 (2024). https:\/\/doi.org\/10.1056\/nejmc2315000","journal-title":"N. Engl. J. Med."},{"key":"4693_CR161","doi-asserted-by":"publisher","unstructured":"G. Papa, R. Cannarella, C. Gusmano et al., Effect of daily insulin delivery variability on glycemic outcomes in patients with type 1 diabetes mellitus using an automated insulin delivery system. Diabetes Res. Clin. Pract. 229 (2025). https:\/\/doi.org\/10.1016\/J.DIABRES.2025.112476","DOI":"10.1016\/J.DIABRES.2025.112476"},{"key":"4693_CR162","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.2337\/DBI23-0028","volume":"73","author":"Y Liu","year":"2024","unstructured":"Y. Liu, S. Wang, Z. Wang et al., Recent Progress in Glucose-Responsive Insulin. Diabetes. 73, 1377\u20131388 (2024). https:\/\/doi.org\/10.2337\/DBI23-0028","journal-title":"Diabetes"},{"key":"4693_CR163","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/S0140-6736(25)01438-2","volume":"406","author":"AG Ziegler","year":"2025","unstructured":"A.G. Ziegler, E. Cengiz, T.W.H. Kay, The future of type 1 diabetes therapy. Lancet. 406, 1520\u20131534 (2025). https:\/\/doi.org\/10.1016\/S0140-6736(25)01438-2","journal-title":"Lancet"},{"key":"4693_CR164","doi-asserted-by":"publisher","unstructured":"W. Liu, J. Zhang, Y. Wang et al., Long-acting glucose-responsive insulin with swift onset-of-action. J. Control Release. 383 (2025). https:\/\/doi.org\/10.1016\/J.JCONREL.2025.113826","DOI":"10.1016\/J.JCONREL.2025.113826"},{"key":"4693_CR165","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.1038\/s41586-024-08042-3","volume":"634","author":"T Hoeg-Jensen","year":"2024","unstructured":"T. Hoeg-Jensen, T. Kruse, C.L. Brand et al., Glucose-sensitive insulin with attenuation of hypoglycaemia. Nat. 2024. 634, 8035 (2024). https:\/\/doi.org\/10.1038\/s41586-024-08042-3","journal-title":"Nat. 2024"},{"key":"4693_CR166","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/ACSMATERIALSAU.4C00138\/ASSET","volume":"5","author":"S Pal","year":"2025","unstructured":"S. Pal, T. Rakshit, S. Saha, D. Jinagal, Glucose-Responsive Materials for Smart Insulin Delivery: From Protein-Based to Protein-Free Design. ACS Mater. Au. 5, 239\u2013252 (2025). https:\/\/doi.org\/10.1021\/ACSMATERIALSAU.4C00138\/ASSET. http:\/\/IMAGES\/LARGE\/MG4C00138_0003.JPEG","journal-title":"ACS Mater. Au"},{"key":"4693_CR167","doi-asserted-by":"publisher","unstructured":"R. Parab, J.M. Feeley, M. Valero et al., (2025) Artificial Intelligence in Diabetes Care: Applications, Challenges, and Opportunities Ahead. Endocr Pract. https:\/\/doi.org\/10.1016\/J.EPRAC.2025.07.008","DOI":"10.1016\/J.EPRAC.2025.07.008"},{"key":"4693_CR168","doi-asserted-by":"publisher","unstructured":"B.A. Perkins, J.L. Sherr, C. Mathieu, Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation. Science. 373 (2021). https:\/\/doi.org\/10.1126\/SCIENCE.ABG4502","DOI":"10.1126\/SCIENCE.ABG4502"},{"key":"4693_CR169","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/J.EPRAC.2025.05.752","volume":"31","author":"MS Hughes","year":"2025","unstructured":"M.S. Hughes, C.J. Levy, The Future of Automated Insulin Delivery Systems. Endocr. Pract. 31, 1162\u20131170 (2025). https:\/\/doi.org\/10.1016\/J.EPRAC.2025.05.752","journal-title":"Endocr. Pract."},{"key":"4693_CR170","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(24)00154-2","volume":"12","author":"B Sheng","year":"2024","unstructured":"B. Sheng, K. Pushpanathan, Z. Guan et al., Artificial intelligence for diabetes care: current and future prospects. Lancet Diabetes Endocrinol. 12, 569\u2013595 (2024). https:\/\/doi.org\/10.1016\/S2213-8587(24)00154-2","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4693_CR171","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/S13098-025-01819-0","volume":"17","author":"X Wang","year":"2025","unstructured":"X. Wang, J. Si, Y. Li et al., Effectiveness and safety of AI-driven closed-loop systems in diabetes management: a systematic review and meta-analysis. Diabetol. Metab. Syndr. 17, 238 (2025). https:\/\/doi.org\/10.1186\/S13098-025-01819-0","journal-title":"Diabetol. Metab. Syndr."},{"key":"4693_CR172","doi-asserted-by":"publisher","DOI":"10.14309\/AJG.0000000000003646","author":"C Varghese","year":"2025","unstructured":"C. Varghese, P.J. Pasricha, T.L. Abell et al., Spectrum of Interstitial Cell of Cajal Deficits in Chronic Gastroduodenal Disorders: Systematic Review and Meta-Analysis. Am. J. Gastroenterol. (2025). https:\/\/doi.org\/10.14309\/AJG.0000000000003646","journal-title":"Am. J. Gastroenterol."},{"key":"4693_CR173","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.2337\/DIABETES.49.10.1731","volume":"49","author":"T \u00d6rd\u00f6g","year":"2000","unstructured":"T. \u00d6rd\u00f6g, I. Takayama, W.K.T. Cheung et al., Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes. 49, 1731\u20131739 (2000). https:\/\/doi.org\/10.2337\/DIABETES.49.10.1731","journal-title":"Diabetes"},{"key":"4693_CR174","doi-asserted-by":"publisher","unstructured":"H. Li, W. Cao, X. Zhang, Bin et al., Atractylenolide-1 alleviates gastroparesis in diabetic rats by activating the stem cell factor\/c-kit signaling pathway. Mol. Med. Rep. 24 (2021). https:\/\/doi.org\/10.3892\/MMR.2021.12331","DOI":"10.3892\/MMR.2021.12331"},{"key":"4693_CR175","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1053\/J.GASTRO.2020.12.062","volume":"160","author":"R Singh","year":"2021","unstructured":"R. Singh, S.E. Ha, L. Wei et al., miR-10b-5p Rescues Diabetes and Gastrointestinal Dysmotility. Gastroenterology. 160, 1662\u20131678e18 (2021). https:\/\/doi.org\/10.1053\/J.GASTRO.2020.12.062","journal-title":"Gastroenterology"},{"key":"4693_CR176","doi-asserted-by":"publisher","unstructured":"B.M. Mussa, A.A. Khan, A. Srivastava, S.H. Abdallah, Differentiated PDGFR\u03b1-Positive Cells: A Novel In-Vitro Model for Functional Studies of Neuronal Nitric Oxide Synthase. Int. J. Mol. Sci. 22 (2021). https:\/\/doi.org\/10.3390\/IJMS22073514","DOI":"10.3390\/IJMS22073514"},{"key":"4693_CR177","doi-asserted-by":"publisher","unstructured":"J. Zhou, M.D. O\u2019Connor, V. Ho, The Potential for Gut Organoid Derived Interstitial Cells of Cajal in Replacement Therapy. Int. J. Mol. Sci. 2017. 18 (2017). Page 2059 18:2059. https:\/\/doi.org\/10.3390\/IJMS18102059","DOI":"10.3390\/IJMS18102059"},{"key":"4693_CR178","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.3748\/WJG.V22.I23.5353","volume":"22","author":"H Li","year":"2016","unstructured":"H. Li, Y. Chen, S. Liu, X.H. Hou, Long-pulse gastric electrical stimulation protects interstitial cells of Cajal in diabetic rats via IGF-1 signaling pathway. World J. Gastroenterol. 22, 5353\u20135363 (2016). https:\/\/doi.org\/10.3748\/WJG.V22.I23.5353","journal-title":"World J. Gastroenterol."},{"key":"4693_CR179","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/J.NEUROM.2021.10.003","volume":"25","author":"Y Chen","year":"2022","unstructured":"Y. Chen, S. Zhang, Y. Li et al., Gastric Electrical Stimulation Increases the Proliferation of Interstitial Cells of Cajal and Alters the Enteric Nervous System in Diabetic Rats. Neuromodulation. 25, 1106\u20131114 (2022). https:\/\/doi.org\/10.1016\/J.NEUROM.2021.10.003","journal-title":"Neuromodulation"},{"key":"4693_CR180","doi-asserted-by":"publisher","DOI":"10.1007\/S00592-025-02578-0","author":"Y Lu","year":"2025","unstructured":"Y. Lu, W. Wei, H. Chen et al., Investigating the role of IGF-1 in diabetic gastroparesis: a preliminary review. Acta Diabetol. (2025). https:\/\/doi.org\/10.1007\/S00592-025-02578-0","journal-title":"Acta Diabetol."},{"key":"4693_CR181","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/SCTM.19-0316","volume":"9","author":"P Dadhich","year":"2020","unstructured":"P. Dadhich, K.N. Bitar, Functional restoration of ex vivo model of pylorus: Co-injection of neural progenitor cells and interstitial cells of Cajal. Stem Cells Transl Med. 9, 713\u2013723 (2020). https:\/\/doi.org\/10.1002\/SCTM.19-0316","journal-title":"Stem Cells Transl Med."},{"key":"4693_CR182","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/JGH.14045","volume":"33","author":"JM Park","year":"2018","unstructured":"J.M. Park, S.H. Lee, K. Kim, Il et al., Feasibility of intraperitoneal placental-derived mesenchymal stem cell injection in stomachs of diabetic mice. J. Gastroenterol. Hepatol. 33, 1242\u20131247 (2018). https:\/\/doi.org\/10.1111\/JGH.14045","journal-title":"J. Gastroenterol. Hepatol."},{"key":"4693_CR183","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1053\/J.GASTRO.2009.09.023","volume":"137","author":"JD Huizinga","year":"2009","unstructured":"J.D. Huizinga, N. Zarate, G. Farrugia, Physiology, injury and recovery of interstitial cells of Cajal: basic and clinical science. Gastroenterology. 137, 1548 (2009). https:\/\/doi.org\/10.1053\/J.GASTRO.2009.09.023","journal-title":"Gastroenterology"},{"key":"4693_CR184","doi-asserted-by":"publisher","unstructured":"J. Lu, X. Ma, L. Zhang et al., Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: A preliminary study. Diabetes Res. Clin. Pract. 161 (2020). https:\/\/doi.org\/10.1016\/J.DIABRES.2020.108032","DOI":"10.1016\/J.DIABRES.2020.108032"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04693-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04693-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04693-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:27:12Z","timestamp":1782214032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04693-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":184,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4693"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04693-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"211"}}